The FOUNDATION FOR THE DEVELOPMENT OF AFRICA proudly presents you with the following information that may add value to Africa's development. Please direct any correspondence to: info@isupportafrica.com

HIV/AIDS
The HIV/Aids pandemic is one of the greatest risks the world has ever faced.

The implicit consequences of the HIV/Aids pandemic will require a commitment from everyone and a strategic response, intensive planning and immediate action to minimise the impact on business, industries and economies.

Africa is the worst affected continent, and Sub-Saharan Africa is the worst affected region in the world, with 25 million people living with HIV.

2003 saw an estimated 3 million new HIV infections and 2.2 million AIDS-related deaths in this region. Almost 2 million children under 15 are HIV positive and there are more than 12 million Aids orphans.

South Africa has the highest infection rate of any country on the entire planet.

Only now is the extent of the pandemic becoming clearer and the AIDS death toll is expected to peak in the next 10 years.

We have now dedicated a section of our world-rated website to this very important issue. We welcome any comments and contributions to this section - because

GLOBAL FORUM ON INTERNATIONAL INVESTMENT - CONCLUSION
The key conclusions to the OECD GFII held in Delhi is available from our website. I have dedicated a section in our world-rated website dealing with OECD matters - see:
http://www.foundation-development-africa.org/africa_development/oecd/index.htm

TIPS ON NETWORKING - FDA NETWORKING 'HAPPY HOUR' SESSIONS
Our NETWORKING SESSIONS are working and some useful deals are being concluded.

I received the following recommendation via email recently:
03 November 2004
I recently started attending the Pretoria Happy Hours - and have met several people with whom I will probably do business in the foreseeable future. A couple of them contacted me via Email the following day - but did not specifically identify themselves as FDA contacts. With the email Spam that I get deluged with every day, I nearly deleted two of the emails that actually were relevant - as the Subject line firstly did not identify that they were a FDA contact, and secondly the subject line was pretty generic e.g. 'Printers and consumables'. A name that is not immediately recognisable combined with a generic subject line will invariably get deleted - unopened.
I see that you prefix your email subject lines with 'FDA - as I do.
Could you make your (networking) contacts aware of this issue - as their networking might be undone by 'loose' email habits.
Regards
Jeff Walters
Managing Director
IntelliNova (Pty) Ltd

Thank you Jeff!

Do not forget these "must attend" FDA NETWORKING 'HAPPY HOUR' SESSIONS taking place - opportunities abound - only if you are there!

Herewith the list of our current events:
http://www.foundation-development-africa.org/africa_networking/casual/index.htm

FDA NETWORKING 'HAPPY HOUR' Hilton Durban, in Durban South Africa, every Wednesday from 17H00.
(In association with TBDC (Thekwini Business Development Centre) and the GG Group of Companies)

FDA NETWORKING 'HAPPY HOUR' at the Sheraton Hotel Pretoria, South Africa every Thursday from 17H00
(In association with City of Tshwane Metropolitan Municipality and the (GNCCI) Gauteng North Chamber of Commerce & Industry)

THE COMMISSION ON AFRICA
On Friday, 05 November 2004, I represented the FDA JCCI and Nafcoc at workshop, organised by the Commonwealth Business Council on behalf of The Commission for Africa, an independent international commission set up by the United Kingdom (Tony BLAIR) to take a fresh look at how the international community can do more to support Africa's development.

See: www.commissionforafrica.org

More information on this very interesting initiative will be made available later this week.

FDA PARTNER PROGRAMME NETWORK
Please support our FDA PARTNERS - a network on its own!
See the colorful list of FDA PARTNER logos - impressive:
http://www.fdapartners.net/com/logodisplaylist.htm
See why you should participate in this FDA PARTNER PROGRAMME:
http://www.fdapartners.net/com/why_participate.htm